[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 256777, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 57183, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.108, "open": 0.11, "dayLow": 0.095, "dayHigh": 0.114, "regularMarketPreviousClose": 0.108, "regularMarketOpen": 0.11, "regularMarketDayLow": 0.095, "regularMarketDayHigh": 0.114, "payoutRatio": 0.0, "beta": 3.186, "volume": 362108, "regularMarketVolume": 362108, "averageVolume": 726107, "averageVolume10days": 1314320, "averageDailyVolume10Day": 1314320, "bid": 0.1103, "ask": 0.1126, "bidSize": 35000, "askSize": 59800, "marketCap": 10376173, "fiftyTwoWeekLow": 0.095, "fiftyTwoWeekHigh": 0.55, "allTimeHigh": 1.39, "allTimeLow": 0.037, "fiftyDayAverage": 0.26888, "twoHundredDayAverage": 0.20603, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9252960, "profitMargins": 0.0, "floatShares": 73109244, "sharesOutstanding": 91019065, "heldPercentInsiders": 0.19271, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 94127954, "bookValue": 0.011, "priceToBook": 10.363636, "lastFiscalYearEnd": 1748649600, "nextFiscalYearEnd": 1780185600, "mostRecentQuarter": 1748649600, "netIncomeToCommon": -1526106, "trailingEps": -0.01, "enterpriseToEbitda": -6.076, "52WeekChange": -0.36666667, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 0.114, "recommendationKey": "none", "totalCash": 1123213, "totalCashPerShare": 0.012, "ebitda": -1522926, "totalDebt": 0, "quickRatio": 3.11, "currentRatio": 3.11, "returnOnAssets": -0.48466, "returnOnEquity": -0.922, "freeCashflow": -653390, "operatingCashflow": -1210018, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "PHRRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "corporateActions": [], "regularMarketTime": 1760054400, "exchange": "OQB", "messageBoardId": "finmb_671235862", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 5.555553, "regularMarketPrice": 0.114, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.01, "fiftyDayAverageChange": -0.15488002, "fiftyDayAverageChangePercent": -0.5760191, "twoHundredDayAverageChange": -0.092029996, "twoHundredDayAverageChangePercent": -0.4466825, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newscope Capital Corporation", "nameChangeDate": "2025-10-10", "cryptoTradeable": false, "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 726107, "fiftyTwoWeekLowChange": 0.019000001, "fiftyTwoWeekLowChangePercent": 0.20000002, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "regularMarketChange": 0.0059999973, "regularMarketDayRange": "0.095 - 0.114", "fiftyTwoWeekRange": "0.095 - 0.55", "fiftyTwoWeekHighChange": -0.43600002, "fiftyTwoWeekHighChangePercent": -0.7927273, "fiftyTwoWeekChangePercent": -36.666668, "earningsTimestampStart": 1745524800, "earningsTimestampEnd": 1745524800, "displayName": "PharmaTher", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]